ArticleInvestigational new drugs2014

Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies.

Francois Goldwasser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.